DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG ENROLLMENT Trademark
Trademark Overview
On Wednesday, May 29, 2019, a trademark application was filed for DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG ENROLLMENT with the United States Patent and Trademark Office. The USPTO has given the DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG ENROLLMENT trademark a serial number of 88451504. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, March 9, 2020. This trademark is owned by Bayer HealthCare Pharmaceuticals Inc.. The DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG ENROLLMENT trademark is filed in the Advertising, Business and Retail Services category with the following description:
Business administration of patient reimbursement programs; Administering pharmacy reimbursement support programs and services; Business management of reimbursement programs for others; Strategic business planning and consultation in the field of reimbursement support for pharmaceutical products; Administering pharmaceutical reimbursement support programs and services; Specialized retail pharmacy services to enable "specialty care at retail programs" for patients using specialty medications; Specialized retail, mail order and wholesale pharmacy services enabling patients to access co-pay assistance and other funding sources to pay for specialty medications
General Information
| Serial Number | 88451504 |
| Word Mark | DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG ENROLLMENT |
| Filing Date | Wednesday, May 29, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, March 9, 2020 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of the word DUDE with a curved line and a dot over the second D. Above the word DUDE is the phrase ACCESS SERVICES and below that is the phrase Darolutamide User Drug Enrollment. |
| Goods and Services | Business administration of patient reimbursement programs; Administering pharmacy reimbursement support programs and services; Business management of reimbursement programs for others; Strategic business planning and consultation in the field of reimbursement support for pharmaceutical products; Administering pharmaceutical reimbursement support programs and services; Specialized retail pharmacy services to enable "specialty care at retail programs" for patients using specialty medications; Specialized retail, mail order and wholesale pharmacy services enabling patients to access co-pay assistance and other funding sources to pay for specialty medications |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 13, 2019 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Bayer HealthCare Pharmaceuticals Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Whippany, NJ 07981 |
Trademark Events
| Event Date | Event Description |
| Monday, March 9, 2020 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Monday, March 9, 2020 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, August 22, 2019 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Thursday, August 22, 2019 | PRIORITY ACTION E-MAILED |
| Thursday, August 22, 2019 | PRIORITY ACTION WRITTEN |
| Monday, August 19, 2019 | ASSIGNED TO EXAMINER |
| Friday, June 14, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, June 13, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, June 1, 2019 | NEW APPLICATION ENTERED IN TRAM |
